Back to News & Events

Alexandria Center for Life Science

Location


450 East 29th Street
New York
NY
10016

Next Event

No upcoming events

Loading Map….

Upcoming Events

  • No events in this location
  • Related Stories

    WP_Query Object
    (
        [query] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
            )
    
        [query_vars] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
                [error] => 
                [m] => 
                [p] => 0
                [post_parent] => 
                [subpost] => 
                [subpost_id] => 
                [attachment] => 
                [attachment_id] => 0
                [name] => 
                [pagename] => 
                [page_id] => 0
                [second] => 
                [minute] => 
                [hour] => 
                [day] => 0
                [monthnum] => 0
                [year] => 0
                [w] => 0
                [category_name] => 
                [tag] => 
                [cat] => 
                [tag_id] => 
                [author] => 
                [author_name] => 
                [feed] => 
                [tb] => 
                [paged] => 0
                [meta_key] => 
                [meta_value] => 
                [preview] => 
                [s] => 
                [sentence] => 
                [title] => 
                [fields] => 
                [menu_order] => 
                [embed] => 
                [category__in] => Array
                    (
                    )
    
                [category__not_in] => Array
                    (
                    )
    
                [category__and] => Array
                    (
                    )
    
                [post__in] => Array
                    (
                    )
    
                [post__not_in] => Array
                    (
                    )
    
                [post_name__in] => Array
                    (
                    )
    
                [tag__in] => Array
                    (
                    )
    
                [tag__not_in] => Array
                    (
                    )
    
                [tag__and] => Array
                    (
                    )
    
                [tag_slug__in] => Array
                    (
                    )
    
                [tag_slug__and] => Array
                    (
                    )
    
                [post_parent__in] => Array
                    (
                    )
    
                [post_parent__not_in] => Array
                    (
                    )
    
                [author__in] => Array
                    (
                    )
    
                [author__not_in] => Array
                    (
                    )
    
                [search_columns] => Array
                    (
                    )
    
                [ignore_sticky_posts] => 
                [suppress_filters] => 
                [cache_results] => 1
                [update_post_term_cache] => 1
                [update_menu_item_cache] => 
                [lazy_load_term_meta] => 1
                [update_post_meta_cache] => 1
                [nopaging] => 
                [comments_per_page] => 50
                [no_found_rows] => 
                [order] => 
            )
    
        [tax_query] => WP_Tax_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => AND
                [table_aliases:protected] => Array
                    (
                    )
    
                [queried_terms] => Array
                    (
                    )
    
                [primary_table] => wp_posts
                [primary_id_column] => ID
            )
    
        [meta_query] => WP_Meta_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => 
                [meta_table] => 
                [meta_id_column] => 
                [primary_table] => 
                [primary_id_column] => 
                [table_aliases:protected] => Array
                    (
                    )
    
                [clauses:protected] => Array
                    (
                    )
    
                [has_or_relation:protected] => 
            )
    
        [date_query] => 
        [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
    					 FROM wp_posts 
    					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
    					 
    					 ORDER BY RAND()
    					 LIMIT 0, 3
        [posts] => Array
            (
                [0] => WP_Post Object
                    (
                        [ID] => 4804
                        [post_author] => 4
                        [post_date] => 2025-03-20 12:10:54
                        [post_date_gmt] => 2025-03-20 16:10:54
                        [post_content] => 
    

    The Center for Biotechnology is pleased to announce a request for proposals for our Research Evaluation and Commercialization Hub (REACH) award program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo.) Details on the full funding program overview and proposal guidelines can be found here.

    The development of promising innovations often stalls due to limited early-stage funding to address translational uncertainties. The Center for Biotechnology's Research Evaluation and Commercialization Hub (REACH) award program bridges the translation gap between biomedical discovery and their development toward commercial goals. Program funding is intended to determine feasibility, develop proof-of-concept, and ultimately lead to follow-on funding, a strategic partnership, or company formation.

    The REACH program supports faculty and postdoctoral researchers in translating bio-based, bio-convergence, and bio-medical research discoveries by providing targeted funding and strategic guidance to bridge the translation gap between discovery and development for commercialization.

    Learn more about the program, get information session details and access the full request for proposals here: https://centerforbiotechnology.org/what-we-do/technology-development/reach/

    [post_title] => Funding Opportunity: Research Evaluation and Commercialization Hub (REACH)Awards [post_excerpt] => The Center for Biotechnology is pleased to announce a request for proposals for our REACH award program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo.) [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => news-reach25 [to_ping] => [pinged] => [post_modified] => 2025-03-24 12:11:36 [post_modified_gmt] => 2025-03-24 16:11:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4804 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 4488 [post_author] => 4 [post_date] => 2024-10-24 10:45:00 [post_date_gmt] => 2024-10-24 14:45:00 [post_content] =>

    Governor Kathy Hochul has unveiled plans for New York BioGenesis Park, a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub in Nassau County, Long Island. To be developed by The Albanese Organization, Inc., this state-of-the-art facility would catalyze CGT research, development, clinical manufacturing, and commercialization across New York State. With a historic $150 million state investment—the largest nationwide for a cell and gene therapy hub—NYBGP would accelerate the delivery of new therapies from lab to patient in New York's diverse communities. This transformative hub aims to establish New York as the leading global destination for CGT innovation, driving economic growth, attracting top talent, and revolutionizing patient care statewide and beyond.

    The Center for Biotechnology is thrilled to be counted as a partner in this effort, and is looking forward to working with our colleagues in the initiative to help catalyze and accelerate life-changing therapies.

    New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization. At full build-out, the 700,000-square-foot park would create an end-to-end Cell and Gene Therapy innovation and supply center, featuring interconnected areas for public engagement, research, manufacturing, and collaboration.

    A cornerstone of New York BioGenesis Park is its incubator, supported by a $50 million investment from ESD's Long Island Investment Fund. This facility will empower early-stage therapeutic developers by offering state-of-the-art wet lab space, shared equipment, office space, and other essential resources. This nurturing environment will provide Cell and Gene Therapy companies with access to specialized equipment, mentoring, and stage-appropriate financial guidance. As a critical component of New York BioGenesis Park, the incubator is poised to catalyze the growth of promising Cell and Gene Therapy companies by providing them with resources and support, unlocking their potential for innovation and success.

    New York BioGenesis Park would foster strong ties with academic and medical institutions throughout New York, creating a robust ecosystem for Cell and Gene Therapy innovation. Collaborating with the Empire State Cellular Therapy Consortium and world-class institutions like Cold Spring Harbor Laboratory, the Feinstein Institutes, Northwell Health, Roswell Park, Stony Brook University, Weill Cornell, Columbia University and others around the state, New York BioGenesis Park would enhance research synergies and accelerate medical breakthroughs. This ecosystem would bring together experts in advanced Cell and Gene Therapy therapies, offering specialized facilities, services, and resources to both tenants and collaborating institutions. By facilitating cutting-edge science, innovative technology development and novel approaches to clinical trials, New York BioGenesis Park would ensure New York's institutions remain globally competitive in groundbreaking Cell and Gene Therapy research and commercialization.

    Read the press release of Governor Hochul's announcement here:
    https://www.governor.ny.gov/news/governor-hochul-launches-next-phase-long-islands-nation-leading-cell-and-gene-therapy

    [post_title] => Long Island to be location for Nation-Leading Cell and Gene Therapy Innovation Hub: New York BioGenesis Park. [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => long-island-to-be-location-for-nation-leading-cell-and-gene-therapy-innovation-hub-new-york-biogenesis-park [to_ping] => [pinged] => [post_modified] => 2025-02-26 16:35:20 [post_modified_gmt] => 2025-02-26 21:35:20 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4488 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2210 [post_author] => 3 [post_date] => 2016-05-12 19:03:22 [post_date_gmt] => 2016-05-12 19:03:22 [post_content] => TheraSource LLC, a Feinstein Institute for Medical Research spin-out, has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The grant will support the development of human ghrelin as an innovative treatment to alleviate health damage caused by unintentional radiation exposure. TheraSource has been a client of the Center for Biotechnology and the organization is proud to have played an integral role in the helping the company advance their business and technology strategy. As noted by Diane Fabel, Director of Operations for the Center for Biotechnology, “The Phase II award for TheraSource is a significant landmark for the company and an important milestone for the region.” Ping Wang, MD, founder of TheraSource and Chief of Scientific Officer (CSO) of the Feinstein Institute has stated “Human ghrelin has been investigated in clinical trials of other indications.  With our new findings, we will soon be able to file an Investigational New Drug application to US Food and Drug Administration,” said Dr. Wang. “TheraSource has received investments to fund its various projects and is seeking strategic partnerships towards the goal of clinical development and commercialization.” For more details, read the company’s press release here. [post_title] => TheraSource LLC receives $3M SBIR Grant [post_excerpt] => TheraSource LLC, a Feinstein Institute for Medical Research spin-out, has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => therasource-llc-receives-3m-sbir-grant [to_ping] => [pinged] => [post_modified] => 2016-05-12 19:13:45 [post_modified_gmt] => 2016-05-12 19:13:45 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2210 [menu_order] => 181 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 4231 [post_author] => 4 [post_date] => 2023-07-10 12:37:00 [post_date_gmt] => 2023-07-10 16:37:00 [post_content] =>

    SBU Startup, Lahara Bio, presented in the start-up stadium event at the 2023 BIO International Convention in June.

    Christopher Ashdown, a MD/PhD student at Stony Brook University, and Center for Biotechnology Program alumnus presented on behalf of Lahara after securing a spot in the coveted forum by winning multiple pitch competitions from NIH SEED office.

    According to Ashdown, “Bio 2023 was an amazing experience, and I was thrilled to be able to share the exciting work that we're doing at Lahara Bio with the greater bioscience community. The CfB was incredibly helpful in preparing the company for this conference and has done an excellent job of helping me develop on a personal/professional level".

    In addition to the main stage presentation, Ashdown also presented Lahara Bio at the NIH booth. Lahara Bio was sponsored to attend BIO by the NIH after Ashdown won the national investor pitch competition at the NIH Proof of Concept Network annual meeting this past spring.

    Lahara Bio is an early-stage biotechnology company using cell-specific mechanical vibration to non-invasively improve biomanufacturing outcomes. Learn more about the company and the team behind Lahara at laharabio.com.

    [post_title] => Lahara Bio Presents at BIO International Convention [post_excerpt] => Stony Brook Start Up, Lahara Bio, was presented at the 2023 BIO International Convention by Christopher Ashdown, a MD/PhD student at Stony Brook University, and Center for Biotechnology Program alumnus. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => lahara-bio-presents-at-bio-international-convention [to_ping] => [pinged] => [post_modified] => 2024-08-22 11:32:58 [post_modified_gmt] => 2024-08-22 15:32:58 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4231 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [4] => WP_Post Object ( [ID] => 3368 [post_author] => 3 [post_date] => 2019-09-23 14:41:34 [post_date_gmt] => 2019-09-23 14:41:34 [post_content] => As outlined by MarketWatch, a recent study shows that Stony Brook University as one of the top 10 U.S. colleges and universities that best promote upward mobility. The editorial further outlines many areas in which Stony Brook University is setting up its graduates for success noting that over the past five years, Stony Brook has improved graduation rates across the board. Read the full piece here. [post_title] => Stony Brook University Among Top Colleges for Upward Mobility [post_excerpt] => Stony Brook University "has a high-tech, data-driven focus on student performance and a high-touch, advisor-heavy outreach program to make sure kids stay on track." [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => stony-brook-university-among-top-colleges-for-upward-mobility [to_ping] => [pinged] => [post_modified] => 2019-09-23 20:09:46 [post_modified_gmt] => 2019-09-23 20:09:46 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3368 [menu_order] => 84 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 5 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4804 [post_author] => 4 [post_date] => 2025-03-20 12:10:54 [post_date_gmt] => 2025-03-20 16:10:54 [post_content] =>

    The Center for Biotechnology is pleased to announce a request for proposals for our Research Evaluation and Commercialization Hub (REACH) award program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo.) Details on the full funding program overview and proposal guidelines can be found here.

    The development of promising innovations often stalls due to limited early-stage funding to address translational uncertainties. The Center for Biotechnology's Research Evaluation and Commercialization Hub (REACH) award program bridges the translation gap between biomedical discovery and their development toward commercial goals. Program funding is intended to determine feasibility, develop proof-of-concept, and ultimately lead to follow-on funding, a strategic partnership, or company formation.

    The REACH program supports faculty and postdoctoral researchers in translating bio-based, bio-convergence, and bio-medical research discoveries by providing targeted funding and strategic guidance to bridge the translation gap between discovery and development for commercialization.

    Learn more about the program, get information session details and access the full request for proposals here: https://centerforbiotechnology.org/what-we-do/technology-development/reach/

    [post_title] => Funding Opportunity: Research Evaluation and Commercialization Hub (REACH)Awards [post_excerpt] => The Center for Biotechnology is pleased to announce a request for proposals for our REACH award program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo.) [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => news-reach25 [to_ping] => [pinged] => [post_modified] => 2025-03-24 12:11:36 [post_modified_gmt] => 2025-03-24 16:11:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4804 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 268 [max_num_pages] => 90 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

    Funding Opportunity: Research Evaluation and Commercialization Hub (REACH)Awards

    More Information

    Long Island to be location for Nation-Leading Cell and Gene Therapy Innovation Hub: New York BioGenesis Park.

    More Information

    TheraSource LLC receives $3M SBIR Grant

    More Information

    Lahara Bio Presents at BIO International Convention

    More Information

    Stony Brook University Among Top Colleges for Upward Mobility

    More Information